APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tuberculosis Treatment Drugs Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchTuberculosis Treatment Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Treatment Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Tuberculosis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Treatment Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Treatment Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Tuberculosis Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tuberculosis Treatment Drugs include Labatec Pharma, Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Pfizer, Eli Lilly, Mylan, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tuberculosis Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tuberculosis Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tuberculosis Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tuberculosis Treatment Drugs Market by Company

Labatec Pharma

Lupin

Macleods Pharmaceuticals

Otsuka Pharmaceutical

Pfizer

Eli Lilly

Mylan

Novartis

Johnson & Johnson

Sanofi

Tuberculosis Treatment Drugs Segment by Type

Active TB

Latent TB

Tuberculosis Treatment Drugs Segment by Application

Hospital

Clinic

Drugstore

Tuberculosis Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tuberculosis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Active TB Table 2. Major Company of Latent TB Table 3. Global Tuberculosis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Tuberculosis Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Tuberculosis Treatment Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tuberculosis Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Tuberculosis Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Tuberculosis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Tuberculosis Treatment Drugs Industry Trends Table 25. Tuberculosis Treatment Drugs Industry Drivers Table 26. Tuberculosis Treatment Drugs Industry Opportunities and Challenges Table 27. Tuberculosis Treatment Drugs Industry Restraints Table 28. Global Tuberculosis Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tuberculosis Treatment Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Tuberculosis Treatment Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Tuberculosis Treatment Drugs Sales Share by Company (2021-2026) Table 32. Global Tuberculosis Treatment Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Tuberculosis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tuberculosis Treatment Drugs Major Company Production Sites and Headquarters Table 35. Global Tuberculosis Treatment Drugs Company, Product Type & Application Table 36. Global Tuberculosis Treatment Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tuberculosis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tuberculosis Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tuberculosis Treatment Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tuberculosis Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Tuberculosis Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Tuberculosis Treatment Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tuberculosis Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Tuberculosis Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Tuberculosis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Tuberculosis Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Tuberculosis Treatment Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Tuberculosis Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tuberculosis Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tuberculosis Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Tuberculosis Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Tuberculosis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Labatec Pharma Company Information Table 72. Labatec Pharma Business Overview Table 73. Labatec Pharma Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Labatec Pharma Tuberculosis Treatment Drugs Product Portfolio Table 75. Labatec Pharma Recent Development Table 76. Lupin Company Information Table 77. Lupin Business Overview Table 78. Lupin Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Lupin Tuberculosis Treatment Drugs Product Portfolio Table 80. Lupin Recent Development Table 81. Macleods Pharmaceuticals Company Information Table 82. Macleods Pharmaceuticals Business Overview Table 83. Macleods Pharmaceuticals Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Macleods Pharmaceuticals Tuberculosis Treatment Drugs Product Portfolio Table 85. Macleods Pharmaceuticals Recent Development Table 86. Otsuka Pharmaceutical Company Information Table 87. Otsuka Pharmaceutical Business Overview Table 88. Otsuka Pharmaceutical Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Otsuka Pharmaceutical Tuberculosis Treatment Drugs Product Portfolio Table 90. Otsuka Pharmaceutical Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Tuberculosis Treatment Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. Eli Lilly Company Information Table 97. Eli Lilly Business Overview Table 98. Eli Lilly Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Eli Lilly Tuberculosis Treatment Drugs Product Portfolio Table 100. Eli Lilly Recent Development Table 101. Mylan Company Information Table 102. Mylan Business Overview Table 103. Mylan Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mylan Tuberculosis Treatment Drugs Product Portfolio Table 105. Mylan Recent Development Table 106. Novartis Company Information Table 107. Novartis Business Overview Table 108. Novartis Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Novartis Tuberculosis Treatment Drugs Product Portfolio Table 110. Novartis Recent Development Table 111. Johnson & Johnson Company Information Table 112. Johnson & Johnson Business Overview Table 113. Johnson & Johnson Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Johnson & Johnson Tuberculosis Treatment Drugs Product Portfolio Table 115. Johnson & Johnson Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Tuberculosis Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Sanofi Tuberculosis Treatment Drugs Product Portfolio Table 120. Sanofi Recent Development Table 121. North America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 123. North America Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 124. North America Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Tuberculosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Tuberculosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Tuberculosis Treatment Drugs Market Share by Country (2021-2026) Table 129. North America Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Tuberculosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 133. Europe Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Tuberculosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Tuberculosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Tuberculosis Treatment Drugs Market Share by Country (2021-2026) Table 139. Europe Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Tuberculosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Tuberculosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Tuberculosis Treatment Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Tuberculosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 153. Latin America Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Tuberculosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Tuberculosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Tuberculosis Treatment Drugs Market Share by Country (2021-2026) Table 159. Latin America Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Tuberculosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Tuberculosis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Tuberculosis Treatment Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Tuberculosis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Tuberculosis Treatment Drugs Distributors List Table 174. Tuberculosis Treatment Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Tuberculosis Treatment Drugs Image Figure 2. Global Tuberculosis Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Active TB Image Figure 6. Global Active TB Sales YoY Growth (2021-2032) & (k units) Figure 7. Latent TB Image Figure 8. Global Latent TB Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Tuberculosis Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tuberculosis Treatment Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Tuberculosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Tuberculosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Tuberculosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tuberculosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tuberculosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tuberculosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tuberculosis Treatment Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Drugstore Image Figure 28. Global Drugstore Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Tuberculosis Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tuberculosis Treatment Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Tuberculosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Tuberculosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Tuberculosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tuberculosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tuberculosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tuberculosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tuberculosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tuberculosis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Tuberculosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Tuberculosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tuberculosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tuberculosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tuberculosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Tuberculosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tuberculosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tuberculosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tuberculosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Tuberculosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tuberculosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tuberculosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tuberculosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Tuberculosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tuberculosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tuberculosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tuberculosis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Tuberculosis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tuberculosis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tuberculosis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tuberculosis Treatment Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tuberculosis Treatment Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Active TB
  • Latent TB
Applications
  • Hospital
  • Clinic
  • Drugstore
Companies covered
  • Labatec Pharma
  • Lupin
  • Macleods Pharmaceuticals
  • Otsuka Pharmaceutical
  • Pfizer
  • Eli Lilly
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tuberculosis Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tuberculosis Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tuberculosis Treatment Drugs Market by Type
  6. 1.3.1 Active TB
  7. 1.3.2 Latent TB
  8. 1.4 Global Tuberculosis Treatment Drugs Market Size by Type
  9. 1.4.1 Global Tuberculosis Treatment Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tuberculosis Treatment Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tuberculosis Treatment Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tuberculosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tuberculosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tuberculosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tuberculosis Treatment Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tuberculosis Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tuberculosis Treatment Drugs Industry Trends
  2. 2.2 Tuberculosis Treatment Drugs Industry Drivers
  3. 2.3 Tuberculosis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tuberculosis Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Tuberculosis Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Tuberculosis Treatment Drugs Price (2021-2026)
  4. 3.4 Global Tuberculosis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Tuberculosis Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Tuberculosis Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Tuberculosis Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Tuberculosis Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tuberculosis Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Tuberculosis Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tuberculosis Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tuberculosis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tuberculosis Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Tuberculosis Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tuberculosis Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tuberculosis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tuberculosis Treatment Drugs by Application
  1. 5.1 Tuberculosis Treatment Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Drugstore
  5. 5.2 Global Tuberculosis Treatment Drugs Market Size by Application
  6. 5.2.1 Global Tuberculosis Treatment Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tuberculosis Treatment Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tuberculosis Treatment Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tuberculosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tuberculosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tuberculosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tuberculosis Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tuberculosis Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Labatec Pharma
  2. 6.1.1 Labatec Pharma Company Information
  3. 6.1.2 Labatec Pharma Business Overview
  4. 6.1.3 Labatec Pharma Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Labatec Pharma Tuberculosis Treatment Drugs Product Portfolio
  6. 6.1.5 Labatec Pharma Recent Developments
  7. 6.2 Lupin
  8. 6.2.1 Lupin Company Information
  9. 6.2.2 Lupin Business Overview
  10. 6.2.3 Lupin Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lupin Tuberculosis Treatment Drugs Product Portfolio
  12. 6.2.5 Lupin Recent Developments
  13. 6.3 Macleods Pharmaceuticals
  14. 6.3.1 Macleods Pharmaceuticals Company Information
  15. 6.3.2 Macleods Pharmaceuticals Business Overview
  16. 6.3.3 Macleods Pharmaceuticals Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Macleods Pharmaceuticals Tuberculosis Treatment Drugs Product Portfolio
  18. 6.3.5 Macleods Pharmaceuticals Recent Developments
  19. 6.4 Otsuka Pharmaceutical
  20. 6.4.1 Otsuka Pharmaceutical Company Information
  21. 6.4.2 Otsuka Pharmaceutical Business Overview
  22. 6.4.3 Otsuka Pharmaceutical Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Otsuka Pharmaceutical Tuberculosis Treatment Drugs Product Portfolio
  24. 6.4.5 Otsuka Pharmaceutical Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Tuberculosis Treatment Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Tuberculosis Treatment Drugs Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Tuberculosis Treatment Drugs Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis Tuberculosis Treatment Drugs Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Tuberculosis Treatment Drugs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Tuberculosis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Tuberculosis Treatment Drugs Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Tuberculosis Treatment Drugs Sales by Country
  2. 7.1.1 North America Tuberculosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tuberculosis Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tuberculosis Treatment Drugs Market Size by Country
  6. 7.2.1 North America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tuberculosis Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tuberculosis Treatment Drugs Sales by Country
  2. 8.1.1 Europe Tuberculosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tuberculosis Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tuberculosis Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tuberculosis Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tuberculosis Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Tuberculosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tuberculosis Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tuberculosis Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tuberculosis Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tuberculosis Treatment Drugs Sales by Country
  2. 10.1.1 South America Tuberculosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tuberculosis Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tuberculosis Treatment Drugs Market Size by Country
  6. 10.2.1 South America Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tuberculosis Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tuberculosis Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Tuberculosis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tuberculosis Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tuberculosis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tuberculosis Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Tuberculosis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tuberculosis Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tuberculosis Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tuberculosis Treatment Drugs Value Chain Analysis
  2. 12.1.1 Tuberculosis Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tuberculosis Treatment Drugs Production Mode & Process
  7. 12.2 Tuberculosis Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tuberculosis Treatment Drugs Distributors
  10. 12.2.3 Tuberculosis Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst